GLP-1 agonists are large peptide molecules
A responsible plan may include adequate protein intake, resistance training, walking or other appropriate activity, body composition tracking when available, lab monitoring, gradual dose escalation when appropriate, nutrition support during appetite reduction, hydration and electrolyte guidance, monitoring fatigue or excessive appetite suppression, and evaluation for hormone, thyroid, or nutrient issues when relevant
Obes Sci Amp Pract (2019) 5:36675
Related PDB-101 Resources Browse Drug Action Browse You and Your Health Browse Diabetes Browse Biomolecular Structural Biology References 6LN2: Wu F, Yang L, Hang K, Laursen M, Wu L, Han GW, Ren Q, Roed NK, Lin G, Hanson MA, Jiang H, Wang MW, Reedtz-Runge S, Song G, Stevens RC